Current status of Paragonimus and paragonimiasis in Ecuador

A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy...

Full description

Bibliographic Details
Main Authors: Manuel Calvopiña, Daniel Romero, Byron Castañeda, Yoshihisa Hashiguchi, Hiromu Sugiyama
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2014-11-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000700849&lng=en&tlng=en
_version_ 1797702878645714944
author Manuel Calvopiña
Daniel Romero
Byron Castañeda
Yoshihisa Hashiguchi
Hiromu Sugiyama
author_facet Manuel Calvopiña
Daniel Romero
Byron Castañeda
Yoshihisa Hashiguchi
Hiromu Sugiyama
author_sort Manuel Calvopiña
collection DOAJ
description A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.
first_indexed 2024-03-12T04:57:18Z
format Article
id doaj.art-002d1c9fba1647839fe0865e308cb9ec
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T04:57:18Z
publishDate 2014-11-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-002d1c9fba1647839fe0865e308cb9ec2023-09-03T09:14:42ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80602014-11-01109784985510.1590/0074-0276140042S0074-02762014000700849Current status of Paragonimus and paragonimiasis in EcuadorManuel CalvopiñaDaniel RomeroByron CastañedaYoshihisa HashiguchiHiromu SugiyamaA review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000700849&lng=en&tlng=enParagonimusparagonimiasisreviewepidemiologyzoonosesEcuador
spellingShingle Manuel Calvopiña
Daniel Romero
Byron Castañeda
Yoshihisa Hashiguchi
Hiromu Sugiyama
Current status of Paragonimus and paragonimiasis in Ecuador
Memorias do Instituto Oswaldo Cruz
Paragonimus
paragonimiasis
review
epidemiology
zoonoses
Ecuador
title Current status of Paragonimus and paragonimiasis in Ecuador
title_full Current status of Paragonimus and paragonimiasis in Ecuador
title_fullStr Current status of Paragonimus and paragonimiasis in Ecuador
title_full_unstemmed Current status of Paragonimus and paragonimiasis in Ecuador
title_short Current status of Paragonimus and paragonimiasis in Ecuador
title_sort current status of paragonimus and paragonimiasis in ecuador
topic Paragonimus
paragonimiasis
review
epidemiology
zoonoses
Ecuador
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000700849&lng=en&tlng=en
work_keys_str_mv AT manuelcalvopina currentstatusofparagonimusandparagonimiasisinecuador
AT danielromero currentstatusofparagonimusandparagonimiasisinecuador
AT byroncastaneda currentstatusofparagonimusandparagonimiasisinecuador
AT yoshihisahashiguchi currentstatusofparagonimusandparagonimiasisinecuador
AT hiromusugiyama currentstatusofparagonimusandparagonimiasisinecuador